References
- Colcher D, Hand P, Muti M, Schlom J. A spectrum of monoclonal antibodies reactive with human mammary tumor cells. Proc Natl Acad Sci USA 1981; 78: 3199–3202
- Ohuchi N, Thor A, Nose M, Fujita J, Kyogoku M, Schlom J. Tumor-associated glycoprotein (TAG 72) detected in adenocarcinomas and benign lesions of the stomach. Int J Cancer 1986; 38: 643–650
- Colcher D, Keenan A M, Larson S M, Schlom J. Prolonged binding of a radio-labeled monoclonal antibody (B 72–3) used for the in situ radioimmuno-detection of human colon carcinoma xenografts. Cancer Res 1984; 44: 5744–5751
- Paterson A J, Schlom J, Sears H F, Bennett J, Colcher D. A radioimmunoassay for the detection of a human tumor-associated glycoprotein (TAG 72–3) using monoclonal antibody B 72.3. Int J Cancer 1986; 37: 659–666
- Johnson V G, Schlom J, Peterson A J, Bennett J, Magnani J I, Colcher D. Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B 72.3. Cancer Res 1986; 46: 850–857
- Domschke S, Heptner G, Domschke W. CA 72–4 in comparison with CA 19–9 and CEA. Gut 1988; 29: A1445–1446
- Hermanek P, Sobin L H. TNM classification of malignant tumors. 4th ed. International Union against Cancer, Geneva 1987
- Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybndoma antibodies. Somat Cell Genet 1979; 5: 957–972
- Heptner G, Domschke S, Domschke W. The role of tumor markers in the diagnosis and management of gastro-intestinal cancer. Hepatogastroenterol 1986; 33: 140–144
- Itzkowitz S H, Young S. New carbohydrate tumor markers. Gastroenterology 1986; 90: 491–494
- Klug T L, Sattler M A, Colcher D, Schlom J. Monoclonal antibody immunoradiometric assay for an antigenetic determinant on a novel pancarcinoma antigen (TAG 72). Int J Cancer 1986; 38: 661–669
- Heptner G, Domschke S, Schneider M U, Domschke W. Bedeutung des tumorassoziierten Antigens CA 19–9 in der Differentialdiagnose von Erkrankungen des Pankreas. Dtsch Med Woch-enschr 1985; 110: 624–628
- Klapdor R, Lehmann U, Bahlo M, Greten H, Dal-Lek M, Schreiber W. CA 19–9 in der Diagnostik und Differentialdiagnostik des exkretorischen Pankre-askarzinoms. Tumor Diagnost Ther 1983; 4: 197–201
- Heptner G, Domschke S, Krapf F, Schneider M U, Domschke W. Vergleich der Tumormarker CEA und CA 19–9 in der Diagnostik kolorektaler Erkrankungen. Dtsch Med Wochenschr 1984; 109: 1309–1312
- Go V LW, Zamnchek N. The role of tumor markers in the management of colorectal cancer. Cancer 1982; 50: 2618–2623
- Harmenberg U, Wahren B, Wiechel K L. Tumor marker carbohydrate antigens CA 19–9 and CA 50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreato-biliary tract. Cancer Res 1988; 48: 1985–1988
- Moertel Ch G, O'Fallon J R, Go V LW, O'Connell M J, Thynne G S. The preoperative carcinoembryonic antigen test in the diagnosis, staging and prognosis of colorectal cancer. Cancer 1986; 58: 603–610
- Estaban J M, Colcher D, Sugarbaker P. Quantitative and qualitative aspects of radiolocalization in colon cancer patients of intravenously administrated MAb B 72.3. Int J Cancer 1987; 39: 50–59
- Johnston W W, Szpak C A, Lottich S C, Thor A, Schlom J. Use of a monoclonal antibody (B 72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions. Cancer Res 1985; 45: 1894–1900